Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- CheckyesterdayChange DetectedAdded revision entry v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check8 days agoChange DetectedA new study record version (v3.4.3) was added to the history, and the previous version (v3.4.2) was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history shows a new revision (v3.4.2) added and an older revision (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe record history shows a new revision (v3.4.1) added on 2026-02-04 with a 'Study Status' entry, and the prior revision (v3.4.0) removed on 2025-12-04. These are administrative updates to versioning and do not alter core trial data or visible user content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedUI enhancements include a 'Show glossary' option and color-coded additions/deletions, along with a revision note updated to v3.4.0 and removal of the No FEAR Act Data entry. These are presentation-only changes and do not affect study data or core content.SummaryDifference0.9%

- Check66 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History and the v3.3.3 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.